| abstract |
The present invention is directed to the use of the combination of the peptide compounds Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 (GRP (18-27)) and Ac-His-Trp-Ala-Val-Gly-His-Leu-NH2 (Acetyl-GRP (20-26)) as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease. |